SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-05-006218
Filing Date
2005-11-04
Accepted
2005-11-04 09:32:21
Documents
4
Period of Report
2005-09-30

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. FORM 10-Q b57400aie10vq.htm 10-Q 385288
2 EX-31.1 SECTION 302 CERTIFICATION OF C.E.O. b57400aiexv31w1.htm EX-31.1 5731
3 EX-31.2 SECTION 302 CERTIFICATION OF C.F.O. b57400aiexv31w2.htm EX-31.2 5714
4 EX-32.1 SECTION 906 CERTIFICATIONS b57400aiexv32w1.htm EX-32.1 3637
  Complete submission text file 0000950135-05-006218.txt   401784
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 051178702
SIC: 2836 Biological Products, (No Diagnostic Substances)